Crossmark

FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma

Published Online: 2015-09-03

Authors

Horn, Kevin P.

Yap, Jeffrey T. https://orcid.org/0000-0001-5306-2860
Agarwal, Neeraj

Morton, Kathryn A.

Kadrmas, Dan J.

Beardmore, Britney

Butterfield, Regan I.

Boucher, Kenneth

Hoffman, John M.
License Information

Text and Data Mining valid from 2015-09-03

Version of Record valid from 2015-09-03
More Information

Article History

Received: 6 April 2015

Accepted: 11 August 2015

First Online: 3 September 2015

Document is current